Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.
about
Historical review of the causes of cancerRecent advances in vaccination of non-responders to standard dose hepatitis B virus vaccineEarly-life exposures to infectious agents and later cancer developmentEnvironmental Exposures and Hepatocellular CarcinomaThe impact of new vaccine introduction on immunization and health systems: a review of the published literatureThe clinical implications of hepatitis B virus genotypes and HBeAg in pediatricsStrategy vaccination against Hepatitis B in ChinaEpidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries.Identifying and prioritizing strategies for comprehensive liver cancer control in Asia.Response to booster doses of hepatitis B vaccine among young adults who had received neonatal vaccination.Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization.Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity regionAccelerating the introduction of rotavirus immunization in Indonesia.A 10-year population-based nationwide descriptive analysis of pediatric emergency care.Fulminant hepatic failure and acute renal failure as manifestations of concurrent Q fever and cytomegalovirus infection: a case report.Post-transplant malignancy in liver transplantation: a single center experiencePersistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers.Seroprevalence of hepatitis B virus surface antigen (HBsAg) among clients visiting 'Tefera Hailu' memorial hospital, Sekota, Northern Ethiopia.Gastroenterology in developing countries: issues and advances.Association Between Chronic Hepatitis B Virus Infection and Risk of Osteoporosis: A Nationwide Population-Based Study.Factors relating to acceptance of hepatitis B virus vaccination by nursing students in a tertiary hospital, PakistanChronic hepatitis B in Asian women of childbearing age.The Emergent Concern of Hepatitis B globally with special attention to Kingdom of Saudi Arabia.Cancer trends in Taiwan.Hepatitis B infection in Vietnam: current issues and future challenges.Natural history of chronic hepatitis B REVEALed.Countering hepatitis B virus infection using RNAi: how far are we from the clinic?Mother-to-child transmission of HBV: review of current clinical management and prevention strategies.Essential components in developing public policy to control viral hepatitis: lessons from Taiwan.The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.Elevated ALT and GGT predict all-cause mortality and hepatocellular carcinoma in Taiwanese male: a case-cohort study.Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study.Higher disappearance rate of anti-HBs in Taiwanese freshers neonatally vaccinated with recombinant yeast hepatitis B vaccine.Vertical transmission of hepatitis B virus during pregnancy and delivery in Denmark.Clinical Impact of Viral Load on the Development of Hepatocellular Carcinoma and Liver-Related Mortality in Patients with Hepatitis C Virus Infection.Relationship between chronic hepatitis B and metabolic syndrome: A structural equation modeling approach.Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees.
P2860
Q26767036-76C3D968-AC42-4914-B18A-6A7873BA79EEQ26777516-7C2015BF-15C8-4627-97B7-687EC787D0BDQ26786103-68D8C3ED-5C17-48B5-BFA8-F5AD97A23148Q27004319-0EAA9771-101D-4EDB-8E75-2ADD2D183446Q27009450-8C9A983D-B061-43F4-8E20-90E86EB17A3CQ28073299-8BEE1AA4-A123-493D-A7EB-A9FE93F8B30CQ28081068-ADB439F1-79AB-46E1-AA26-496F925F4037Q30244568-5A1B568D-D16B-49F3-985C-83FDF81BADBCQ33318588-A292EF50-A250-483F-AE2B-4B0A21AD3D9CQ34065382-62AFFBA9-70F9-442C-841F-B27400D3340FQ34150102-2B3C9CA0-B6F5-4766-9F03-BC7193C9DDC2Q34271615-641FA301-497E-47E6-8BAD-87BA7BCE9B47Q34581747-8F0A2D8C-3767-45B2-8CBE-B5EB412108E8Q35033602-BE434145-9067-4498-97FB-0C7A45F3874AQ35104621-C456A511-3EC3-4A89-BB95-1BC7169179F0Q35144664-9061351F-6D77-462C-9B48-7422EEB6DBBFQ35500780-DC5906C9-349E-4107-A0D5-5EA3BD75B53CQ36154140-6C44EE40-FF88-4EDA-9E69-653EE0224B27Q36391894-1F777591-B1B1-4A71-AB65-BDA11A81FA8BQ37160714-592E16C8-9128-466A-A173-6BD1974DAEB3Q37233997-C11BD249-4239-4E89-9172-7AE6AE8FA3E2Q37328367-5B1C9949-2A76-4008-92E8-C66E46902F9BQ37339586-BBF8116D-7B57-41F2-8F7E-55D5570A9FF4Q37380063-08EDD53F-1FE2-4A10-BB5D-1B1069CC6AC1Q37577719-E505A1EB-3474-464C-808F-69749913319FQ37759972-26ACD744-4008-4B97-9996-1067D196EB31Q37821140-B60AAD9B-5EC4-48D0-9CC2-B4695BC46291Q37842664-FBA105CC-FEA1-441D-A795-B09CF66D9ADCQ37931159-B9CDFFA1-90DA-4EEC-BBD8-D25C1918CED2Q38222498-46CD7C17-CB87-4EF7-B414-DC8EC1DC9ACBQ38581096-C8DB31A5-07A8-482A-9253-17024D1FB8E1Q38674210-9EAA9626-BA78-40DC-BA70-463C1164A051Q39343370-DF489B68-86AD-4A8B-8165-A5E7499B8A22Q39419887-DB47996E-E5A5-48A4-8895-742F55EA7A66Q40259316-AA2D0F32-6652-42D2-AA83-D1C330C00CF8Q40475167-2B2CD1D6-2C04-4819-AE4C-228A8F95BC6CQ40531340-B0DE281D-5D16-417B-8DE0-52C0F1686782Q40849868-1221BF01-9971-47D4-BB96-DDF92E64C7B4Q42177592-3FD01D14-1EA5-44CA-8FE6-68742A12ABB7Q42229775-982B7955-EAE3-4C8B-9C42-128481E67908
P2860
Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Nationwide hepatitis B vaccina ...... 0 years after it was launched.
@ast
Nationwide hepatitis B vaccina ...... 0 years after it was launched.
@en
type
label
Nationwide hepatitis B vaccina ...... 0 years after it was launched.
@ast
Nationwide hepatitis B vaccina ...... 0 years after it was launched.
@en
prefLabel
Nationwide hepatitis B vaccina ...... 0 years after it was launched.
@ast
Nationwide hepatitis B vaccina ...... 0 years after it was launched.
@en
P2093
P356
P1476
Nationwide hepatitis B vaccina ...... 20 years after it was launched
@en
P2093
Chien-Jen Chen
Hsu-Sung Kuo
Yin-Chu Chien
P304
P356
10.1093/EPIREV/MXJ010
P577
2006-06-16T00:00:00Z